LINC01618

Across TCGA pan-cancer cohorts, LINC01618 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC01618’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC01618 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01618 is over-expressed in tumor, although a few such as KIRC and KICH show the opposite, repressed pattern.

HNSC, KIRC, and KICH are the cancer types where LINC01618 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01618 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.051	.003	7	view →
KIRC	All	All	−0.057	<.001	6	view →
KICH	All	All	−0.145	<.001	4	view →
LUSC	All	All	+0.092	<.001	4	view →
ESCA	Female	All	+0.233	.014	1	view →
COAD	All	II,III,IV	+0.060	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

LINC01618–HNSC

Open the HNSC breakdown →